Abstract: The invention is directed to purified and isolated novel TSLP polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
Type:
Grant
Filed:
May 9, 2001
Date of Patent:
April 29, 2003
Assignee:
Immunex Corporation
Inventors:
John E. Sims, Stewart D. Lyman, Hilary J. McKenna, Allison P. Armstrong